Scott Coiante
2017
In 2017, Scott Coiante earned a total compensation of $635.9K as Sr. VP and Chief Financial Officer at Agile Therapeutics, a 22% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $56,245 |
|---|---|
| Option Awards | $153,000 |
| Salary | $319,833 |
| Stock Awards | $79,100 |
| Other | $27,711 |
| Total | $635,889 |
Coiante received $319.8K in salary, accounting for 50% of the total pay in 2017.
Coiante also received $56.2K in non-equity incentive plan, $153K in option awards, $79.1K in stock awards and $27.7K in other compensation.
Rankings
In 2017, Scott Coiante's compensation ranked 10,984th out of 14,666 executives tracked by ExecPay. In other words, Coiante earned more than 25.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,984 out of 14,666 | 25th |
Division Manufacturing | 4,298 out of 5,772 | 26th |
Major group Chemicals And Allied Products | 1,552 out of 2,075 | 25th |
Industry group Drugs | 1,272 out of 1,731 | 27th |
Industry Pharmaceutical Preparations | 991 out of 1,333 | 26th |
Source: SEC filing on April 25, 2018.
Coiante's colleagues
We found two more compensation records of executives who worked with Scott Coiante at Agile Therapeutics in 2017.